MicroPort NeuroScientific Corporation (HKG:2172)

Market Cap	8.49B
Revenue (ttm)	810.65M
Net Income (ttm)	270.48M
Shares Out	575.53M
EPS (ttm)	0.47
PE Ratio	31.58
Forward PE	29.41
Dividend	0.22 (1.50%)
Ex-Dividend Date	Jul 2, 2025

Volume	6,756,000
Average Volume	20,672,159
Open	14.62
Previous Close	14.65
Day's Range	14.44 - 14.78
52-Week Range	6.85 - 19.06
Beta	-0.14
RSI	53.58
Earnings Date	Aug 26, 2025

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk, a 3D electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 527
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2172

Financial Performance

In 2024, MicroPort NeuroScientific's revenue was 761.76 million, an increase of 14.44% compared to the previous year's 665.62 million. Earnings were 254.17 million, an increase of 74.63%.

Financial numbers in CNY